Circular RNAs as Potential Biomarkers and Therapeutic Targets for Metabolic Diseases
Author:
- 28 March 2019
- book chapter
- Published by Springer Nature
- Vol. 1134, 177-191
Abstract
Epidemiological studies provide evidence of a continuous rise in metabolic diseases throughout industrialized countries. Metabolic diseases are commonly associated with different abnormalities that hold a key role in the emergence and progression of frequent disorders including diabetes mellitus (DM), non-alcoholic fatty liver disease (NAFLD), obesity, metabolic syndrome and cardiovascular diseases. The burden of metabolic diseases is believed to arise through complex interaction between genetic and epigenetic factors, lifestyle changes and environmental exposure to triggering stimuli. The diagnosis and treatment of metabolic disorders continue to be an overwhelming challenge. Thus, the development of novel biomarkers may enhance the accuracy of the diagnosis at an early stage of the disease and allow effective intervention. Over the past decade, progress has been made in exploring the potential role of noncoding RNAs (ncRNAs) in the regulation of gene networks involved in metabolic diseases. A growing body of evidence now suggests that aberrant expression of circular RNAs (circRNAs) is relevant to the occurrence and development of metabolic diseases. Accordingly, circRNAs are proposed as predictive biomarkers and potential therapeutic targets for these diseases. As the field of circRNAs is rapidly evolving and knowledge is increasing, the present paper provides current understanding of the regulatory roles of these RNA species mainly in the pathogenesis of DM, NAFLD and obesity. Furthermore, some of the limitations to the promise of circRNAs and perspectives on their future research are discussed.Keywords
This publication has 103 references indexed in Scilit:
- Circular RNAs are abundant, conserved, and associated with ALU repeatsRNA, 2012
- Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery diseaseLipids in Health and Disease, 2012
- Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell TypesPLOS ONE, 2012
- Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver DiseasePLOS ONE, 2011
- Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes StudyDiabetes Care, 2011
- miR-130 Suppresses Adipogenesis by Inhibiting Peroxisome Proliferator-Activated Receptor γ ExpressionMolecular and Cellular Biology, 2011
- AMPK as Target for Intervention in Childhood and Adolescent ObesityJournal of Obesity, 2010
- Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL ExpressionPLOS Genetics, 2010
- miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARγ expressionBiochemical and Biophysical Research Communications, 2010
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007